Weekly round up from Life Sciences Industry.
Varian has acquired privately held CyberHeart, a developer of a non-invasive treatment called radioablation for cardiac arrhythmias.
Financial terms are not disclosed.
Date: May 13, 2019
Source: Seeking Alpha
Send us an email, we will get in touch with you.
Sign up for DistilINFO e-Newsletters.
CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19
A 4.5% Rise in Demand for Pregnancy Point of Care Testing Products Expected By 2028
Evidation Health Nabs $153M to Expand Virtual Health Programs
Endoscopic AI Maker AI Medical Service Scores $70M in Series C Funding
AIA Thailand Partners with True Digital Group and Samitivej to Launch Virtual COVID-19 Clinic
Device Cybersecurity: For Better — and Worse? The Very Connected World of Medical Devices
BioLife Solutions Strengthens Gene Therapy Capabilities with $24 Million Acquisition
Bayer wins EU approval for $62.5 billion Monsanto buy